- view as grid
- view as list
Report Examines How State and National Policies Affect Access to Reproductive Health Care for Low-Income Women in Five Communities
As policy debates over the future of access to reproductive and sexual health services heat up at the national and state levels, this report examines how these policies have played out in five communities across the United States.
This report summarizes the major findings from KFF and HMA case studies in five U.S. communities, highlighting cross-cutting themes and the degree to which low-income women in diverse communities face challenges in accessing reproductive and sexual health care, as well as promising initiatives established by community providers to address barriers and improve access to these basic services.
This fact sheet includes the latest information and data about the Medicare Part D prescription drug benefit, including current plan information, the standard benefit parameters, low-income assistance, the latest available enrollment data, and Part D program spending and financing.
This brief reviews the data from CMS about its 2019 funding awards to Navigator programs serving consumers in the federal marketplace states during the 2020 open enrollment season, as well as funding trends over time. It breaks out the funding by state and identifies counties with no federally funded Navigators available to help consumers.
This chartpack provides data on demographics, health access and utilization, health status and outcomes, and health coverage by race and ethnicity to provide greater insight into the current status of disparities. Where data are available, it examines measures by six groups: White, Black, Hispanic, Asian, American Indian and Alaska Native, and Native Hawaiian and Other Pacific Islander.
Drug prices are at the center of health policy debates at both the state and federal levels. . Policymakers are currently debating significant changes to payment for prescription drugs through Medicare and commercial insurers that may also have implications for Medicaid and the Medicaid Prescription Drug Rebate Program (MDRP). This brief explains the MDRP to help policymakers and others understand how Medicaid pays for drugs and any potential consequences of policy changes for the program.
This Medicaid waiver tracker page aggregates tracking information on pending and approved Section 1115 Medicaid waivers. It includes resources such as an overview map and figure, detailed waiver topic tables, and explanatory briefs.
A new KFF analysis finds donor government support for global family planning efforts totaled US$1.50 billion in 2018, up 19 percent from 2017 (US$1.26 billion) – and the highest level since tracking efforts began following the London Summit on Family Planning in 2012. Since 2012, total donor government funding for family planning…
Donor government support for global family planning efforts totaled US$1.50 billion in 2018, up 19% from 2017 (US$1.26 billion) – and the highest level since tracking efforts began following the London Summit on Family Planning in 2012.